GSK, Plasticell Partner to Produce Hematopoietic Cells from iPSCs

GlaxoSmithKline (GSK) will provide combinations of molecules for screening through Plasticell’s Combinatorial Cell Culture™ (CombiCult ® ) combinatorial stem cell screening technology, through a collaboration whose value was not disclosed.Plasticell will use the bead-based CombiCult platform to produce hematopoietic cells from induced pluripotent stem cells (iPSCs) by optimizing the directed differentiation of the iPSCs to specific blood cell lineages for use by GSK in therapeuti